- Home
- BTBT vs MDXG Comparison
BTBT vs MDXG Comparison
Compare BTBT & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTBT | MDXG |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 640.1M | 530.2M |
| IPO Year | 2017 | 2007 |
Fundamental Metrics
Financial Performance| Metric | BTBT | MDXG |
|---|---|---|
| Price | $2.06 | $3.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $6.00 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 24.9M | 1.1M |
| Earning Date | 05-15-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | N/A | ★ N/A |
| Revenue | $113,560,320.00 | ★ $418,630,000.00 |
| Revenue This Year | $38.96 | N/A |
| Revenue Next Year | $89.41 | $13.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 5.10 | ★ 19.99 |
| 52 Week Low | $1.25 | $3.03 |
| 52 Week High | $4.55 | $7.99 |
Technical Indicators
Market Signals| Indicator | BTBT | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 60.17 | 47.00 |
| Support Level | $1.92 | $3.47 |
| Resistance Level | $2.24 | $3.84 |
| Average True Range (ATR) | 0.17 | 0.14 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 78.23 | 31.25 |
Price Performance
Historical ComparisonAbout BTBT Bit Digital Inc.
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.